Literature DB >> 24904978

Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis.

Matteo Cecchi1, Paolo Messina, Luisa Airoldi, Elisabetta Pupillo, Monica Bandettini di Poggio, Andrea Calvo, Massimiliano Filosto, Christian Lunetta, Jessica Mandrioli, Federica Pisa, Roberta Pastorelli, Ettore Beghi.   

Abstract

The aim of this study was to verify whether abnormalities in plasma amino acid (AA) levels could be biological correlates of the age of onset in amyotrophic lateral sclerosis (ALS). We undertook plasma AA profiling in a large population comprising 117 newly diagnosed ALS patients and 117 matched controls. ALS patients were stratified in early (58 patients aged < 55 years) versus late onset (59 patients aged > 74 years). We applied a rapid and reproducible method for the analysis of AA using amine reactive isotope coded tags in conjunction with liquid chromatography coupled to Multiple Reaction Monitoring-Mass Spectrometry. Results showed that values of only three AA were significantly different in ALS patients and controls. We found lower levels of leucine and higher levels of glutamate and leucine in early-onset ALS compared to their matched controls. In conclusion, different AA patterns related to the ALS age of onset were found, providing insight into possibly aberrant biochemical pathways that might unlock key pathological pathways.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; age at onset; plasma amino acids; spectrometry

Mesh:

Substances:

Year:  2014        PMID: 24904978     DOI: 10.3109/21678421.2014.920032

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  4 in total

Review 1.  Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Lucas T Vu; Robert Bowser
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

2.  Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis.

Authors:  Melania Filareti; Silvia Luotti; Laura Pasetto; Mauro Pignataro; Katia Paolella; Paolo Messina; Elisabetta Pupillo; Massimiliano Filosto; Christian Lunetta; Jessica Mandrioli; Giuseppe Fuda; Andrea Calvo; Adriano Chiò; Massimo Corbo; Caterina Bendotti; Ettore Beghi; Valentina Bonetto
Journal:  Front Mol Neurosci       Date:  2017-04-06       Impact factor: 5.639

Review 3.  Biomarkers in Motor Neuron Disease: A State of the Art Review.

Authors:  Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw
Journal:  Front Neurol       Date:  2019-04-03       Impact factor: 4.003

4.  Homocysteine aggravates ROS-induced depression of transmitter release from motor nerve terminals: potential mechanism of peripheral impairment in motor neuron diseases associated with hyperhomocysteinemia.

Authors:  Ellya Bukharaeva; Anastasia Shakirzyanova; Venera Khuzakhmetova; Guzel Sitdikova; Rashid Giniatullin
Journal:  Front Cell Neurosci       Date:  2015-10-06       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.